
11 - 50 employees
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Avalyn Pharma is a biopharma company dedicated to developing innovative medicines aimed at treating rare lung diseases. The company is currently conducting the MIST Study, a Phase 2b clinical trial assessing the safety and efficacy of an inhaled version of pirfenidone, known as AP01, for patients diagnosed with Progressive Pulmonary Fibrosis (PPF). Through their research, Avalyn Pharma seeks to improve lung function and the overall quality of life for individuals suffering from this serious condition.
🔥 0 minutes ago
🇺🇸 United States – Remote
💵 $220k - $240k / year
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 0%
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Avalyn Pharma is a biopharma company dedicated to developing innovative medicines aimed at treating rare lung diseases. The company is currently conducting the MIST Study, a Phase 2b clinical trial assessing the safety and efficacy of an inhaled version of pirfenidone, known as AP01, for patients diagnosed with Progressive Pulmonary Fibrosis (PPF). Through their research, Avalyn Pharma seeks to improve lung function and the overall quality of life for individuals suffering from this serious condition.
• Report to the Senior Vice President, Clinical Development • Provide IPF/ILD medical oversight, scientific leadership, and clinical expertise throughout the clinical trial lifecycle • Lead clinical trial strategy and protocol development, including endpoints, inclusion/exclusion criteria, and trial design • Define medical monitoring, safety, and risk mitigation strategies with the Medical Monitor • Contribute to statistical analysis plan assumptions and clinical relevance of statistical design • Support site identification and selection based on disease-area expertise • Provide medical input for trial amendments and study-specific regulatory interactions • Serve as disease-state expert and provide medical guidance to the Medical Monitor and clinical trial team • Review SAEs, SUSARs, safety signals, eligibility deviations, protocol exceptions, and violations • Support DSMB and Safety Review Committee materials • Ensure trial conduct meets GCP and patient safety standards • Lead cross-functional collaboration with Clinical Operations, Biostatistics, Regulatory Affairs, Pharmacovigilance, Translational Science, and external CROs • Provide medical guidance to site investigators and resolve clinical or disease-related questions • Conduct site visits as appropriate • Co-lead blinded data review meetings and interpret emerging safety and efficacy data • Lead medical interpretation of safety and efficacy outcomes for Clinical Trial Reports and support interim analyses and futility assessments • Lead development and authoring of the Clinical Study Report • Participate in regulatory agency interactions and co-lead EOP2 materials with Regulatory Affairs • Respond to health authority questions • Present clinical data at advisory boards and investigator meetings and support publications and congress presentations
• Advanced clinical or scientific degree (e.g., APRN, RRT, PhD, PharmD) with 5–7+ years of experience in IPF/ILD clinical care, research, or drug development • A minimum of 3–5+ years of clinical development experience, with demonstrated involvement in the design and execution of Phase 2–3 clinical trials, preferably global studies • Therapeutic expertise in IPF, ILD, or a closely related respiratory disease area is required • Demonstrated expertise in clinical trial protocol development, including endpoints, eligibility criteria, safety monitoring, and risk mitigation strategies • Strong clinical judgment and commitment to patient safety, with experience evaluating safety signals, protocol deviations, and benefit-risk considerations • Experience reviewing and interpreting clinical safety and efficacy data and translating findings into meaningful clinical and development decisions • Working knowledge of ICH-GCP, clinical research standards, and global regulatory requirements, with experience supporting health authority interactions • Proven ability to lead and influence cross-functional teams and collaborate effectively with Clinical Operations, Biostatistics, Regulatory Affairs, Pharmacovigilance, Translational Science, and external partners • Excellent written and verbal communication skills, with the ability to effectively engage investigators, clinical sites, CROs, regulatory agencies, and internal stakeholders • Strong strategic thinking and business judgment, with the ability to connect trial-level decisions to broader clinical development and program objectives • Ability to work effectively in a fast-paced, collaborative environment and balance strategic responsibilities with hands-on involvement in clinical trial execution
Apply Now🔥 4 hours ago
Clinical development director advancing Akero’s MASH treatment, efruxifermin, through Phase 3 trials. Leading medical monitoring, regulatory submissions, data analysis, and scientific disclosures.
🔥 5 hours ago
Medical Director guiding utilization management, quality improvement, and complex medical reviews at Centene. Improving healthcare access, cost-effectiveness, and outcomes for members.
🔥 6 hours ago
Medical Director conducting evidence-based medical necessity reviews for Evernorth, which creates pharmacy, care, and benefit solutions. Consulting providers and guiding appropriate patient treatment.
🔥 9 hours ago
Marketing Director owning integrated campaigns, ABM and demand generation for PatientPoint’s digital healthcare network. Leading provider marketing, sales enablement and a three-person team.
🇺🇸 United States – Remote
💵 $130.6k - $200.4k / year
💰 Venture Round on 2020-01
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
🔥 11 hours ago
Medical Director conducting clinical reviews and case management for Cigna Healthcare. Applying evidence-based guidelines to coverage decisions, appeals, quality initiatives, and clinical consultation.